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The emergence of antibiotic resistant pathogens
poses a significant threat to patients with nosoco-
mial pneumonia. It is therefore important to
evaluate the relationship between hospital-ac-
quired pathogens and antibiotic resistance.
A prospective study was conducted in 100
consecutive patients with hospital-acquired infec-
tions admitted to the intensive care unit of which
46% had clinical, laboratory, and radiological
evidence of nosocomial pneumonia.
Isolated pathogens consisted of Klebsiella spp.
(29%), Pseudomonas spp. (16%), Acinetobacter spp.
(13%), Staphylococcus aureus (11%), EscherichiaAntibiotic resistance in hospital-acquired patho
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med.2005.03.014coli (10%), Enterobacter spp. (9%), methicillin-
resistant S. aureus (2%), and Candida spp. (9%).
Details of antibiotic resistance are shown in
Table 1. Mortality was 33% in patients with
nosocomial pneumonia.
Antibiotic resistance in hospital-acquired patho-
gens is significant and remains a risk to patients
with nosocomial pneumonia.
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